GSK
Pharma

FDA signs off on expansion for GSK's Blujepa to treat gonorrhea

The FDA has signed off on a label expansion for GSK’s Blujepa, which brings an oral option and a new class of antibiotic treatment for gonorrhea.
Kevin Dunleavy Dec 12, 2025 10:30am
two green lights

Innoviva scores FDA nod for gonorrhea drug one day after GSK

Dec 12, 2025 3:31pm
VanNaarden

Lilly shifts oral SERD hopes to its largest oncology trial ever

Dec 12, 2025 11:45am
Traffic light go start restart green light

GSK's long-acting asthma med wins CHMP backing

Dec 12, 2025 11:27am
The exterior of the Centers for Disease Control and Prevention campus in Chamblee Georgia March 18 2025

COVID vaccines reduced hospitalizations among children, CDC finds

Dec 12, 2025 11:23am
Rebranding new name billboard

NanoVibronix rebrand feeds into new focus on ENvue system

Dec 12, 2025 11:00am
More News

Amgen nabs FDA nod for Uplizna in generalized myasthenia gravis

Dec 12, 2025 9:49am

Regulatory tracker: GSK's RSV vaccine slated for wider EU nod

Dec 12, 2025 8:40am

Pfizer-Fosun, Zealand, China's new formulary—Fierce Pharma Asia

Dec 12, 2025 8:15am

Europe's pharma policy overhaul inches closer with new deal

Dec 11, 2025 4:20pm